• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[脑膜炎球菌病的疫情及预防策略]

[Epidemic situation and preventive strategy for meningococcal disease].

作者信息

Shao Z J

机构信息

National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.

出版信息

Zhonghua Yu Fang Yi Xue Za Zhi. 2019 Feb 6;53(2):129-132. doi: 10.3760/cma.j.issn.0253-9624.2019.02.001.

DOI:10.3760/cma.j.issn.0253-9624.2019.02.001
PMID:30744283
Abstract

The incidence of meningococcal disease is generally low globally at present. The epidemics, problems and challenges of meningococcal disease were described in order to provide support for prevention and control of meningococcal disease in China, especially in the areas of disease surveillance, epidemic changes, serogroup witching, vaccines and vaccination strategies and meningococcal group B vaccine development.

摘要

目前,全球范围内脑膜炎球菌病的发病率总体较低。描述了脑膜炎球菌病的流行情况、问题和挑战,以便为中国脑膜炎球菌病的预防和控制提供支持,特别是在疾病监测、流行变化、血清群转换、疫苗和疫苗接种策略以及B群脑膜炎球菌疫苗研发等方面。

相似文献

1
[Epidemic situation and preventive strategy for meningococcal disease].[脑膜炎球菌病的疫情及预防策略]
Zhonghua Yu Fang Yi Xue Za Zhi. 2019 Feb 6;53(2):129-132. doi: 10.3760/cma.j.issn.0253-9624.2019.02.001.
2
Meningococcal disease and control in China: Findings and updates from the Global Meningococcal Initiative (GMI).中国的脑膜炎球菌病与控制:全球脑膜炎球菌倡议(GMI)的研究结果与最新进展。
J Infect. 2018 May;76(5):429-437. doi: 10.1016/j.jinf.2018.01.007. Epub 2018 Feb 12.
3
Serogroup A meningococcal conjugate vaccines in Africa.A 群脑膜炎球菌结合疫苗在非洲。
Expert Rev Vaccines. 2015;14(11):1441-58. doi: 10.1586/14760584.2015.1084232. Epub 2015 Aug 31.
4
Vaccine prevention of meningococcal disease in Africa: Major advances, remaining challenges.疫苗预防非洲的脑膜炎球菌病:重大进展,尚存挑战。
Hum Vaccin Immunother. 2018 May 4;14(5):1107-1115. doi: 10.1080/21645515.2017.1412020. Epub 2018 Jan 16.
5
Evolving meningococcal immunization strategies.不断发展的脑膜炎球菌免疫策略。
Expert Rev Vaccines. 2015 Apr;14(4):505-17. doi: 10.1586/14760584.2015.979799. Epub 2014 Dec 10.
6
The challenge of post-implementation surveillance for novel meningococcal vaccines.新型脑膜炎球菌疫苗实施后监测的挑战。
Vaccine. 2012 May 30;30 Suppl 2:B67-72. doi: 10.1016/j.vaccine.2011.12.126. Epub 2012 Jan 9.
7
[Experts' consensus on immunization with meningococcal vaccines in China].[中国脑膜炎球菌疫苗免疫专家共识]
Zhonghua Liu Xing Bing Xue Za Zhi. 2019 Feb 10;40(2):123-128. doi: 10.3760/cma.j.issn.0254-6450.2019.02.001.
8
[Experts' consensus on immunization with meningococcal vaccines in China].《中国脑膜炎球菌疫苗免疫专家共识》
Zhonghua Yu Fang Yi Xue Za Zhi. 2019 Feb 6;53(2):141-145. doi: 10.3760/cma.j.issn.0253-9624.2019.02.004.
9
Quadrivalent meningococcal conjugated vaccine: a routine or selective vaccine in Europe?
J Infect. 2012 Sep;65(3):193-6. doi: 10.1016/j.jinf.2012.04.008. Epub 2012 Apr 25.
10
Protective efficacy of a serogroup B meningococcal vaccine in Sao Paulo, Brazil.巴西圣保罗B群脑膜炎球菌疫苗的保护效力
Lancet. 1992 Oct 31;340(8827):1074-8. doi: 10.1016/0140-6736(92)93086-3.